Our plain-English summary of Successful treatment of a patient with oligometastatic mesothelioma to the brain, by S.S. Li, D.A. Steimer, S. Coy, et al (JTCVS Techniques, 2020).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: S.S. Li, D.A. Steimer, S. Coy, R. Bueno
- Journal: JTCVS Techniques
- Published: 2020;3:358-360
- Type of article: Case report
- Cited by: 4 articles, as counted by NIH iCite
- Read it: PubMed · Publisher · Free full text
In plain English
This case report from a thoracic surgery program at Brigham and Women's Hospital in Boston described one patient. A 48-year-old man with a history of asbestos exposure was diagnosed with epithelioid mesothelioma of the right pleura. The article gives no details of the exposure. Scans showed disease confined to the right side of the chest. He had radical pleurectomy and decortication with heated chemotherapy during surgery, then 4 cycles of chemotherapy (cisplatin and pemetrexed). Two years later he developed speech problems, and imaging showed a single lesion in the left frontal lobe of the brain, with no disease elsewhere. The lesion was removed and confirmed as epithelioid mesothelioma, and the site was then treated with stereotactic radiation (25 Gy). At the time of reporting he was 5.5 years past pleurectomy and 3.5 years past brain treatment, with no evidence of recurrence. The authors said he was the first of more than 150 long-term survivors at their program to develop a brain metastasis. They proposed offering resection and/or radiation to selected patients with isolated recurrences. As a case report, it describes one person's course.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: case report
- Who was studied: One 48-year-old man with right pleural epithelioid mesothelioma, treated at the authors' program in Boston (Brigham and Women's Hospital)
- Exposure: A history of asbestos exposure. No fiber type, job, product or dose is given.
- Main results:
- Pleural biopsy diagnosed epithelioid type mesothelioma, and staging showed disease localized to the right hemithorax.
- After radical pleurectomy, decortication and intraoperative heated chemotherapy (cisplatin and gemcitabine), final pathologic stage was pT3N0. He then completed 4 cycles of adjuvant cisplatin and pemetrexed.
- Two years after pleurectomy, imaging showed a single lesion in the left frontal lobe of the brain. Restaging found no other sites of disease.
- Pathology of the removed brain mass confirmed epithelioid mesothelioma, with no change to biphasic or sarcomatoid subtype.
- Because of close margins, he received stereotactic radiation (25 Gy) to the surgical bed one month after resection.
- At 5.5 years after pleurectomy and 3.5 years after treatment of the brain lesion, he had no evidence of disease recurrence at the time of reporting.
- The authors reported that this patient is 1 of more than 150 long-term (more than 5 years) survivors at their program, and the first of them to develop an intracranial metastasis.
- The authors' conclusion: The authors proposed that isolated recurrences (brain, adrenal, liver) be discussed in multidisciplinary conference, and that patients at least 1 year after pleurectomy with no other sites of disease be offered resection and/or radiation. They did not advise routine brain imaging for surveillance. They recommended a low threshold for brain CT or MRI in mesothelioma patients with new neurologic complaints. They anticipated more distant recurrences as local control of disease improves.
Topics
Medical terms in this study, explained in our Lexicon: Mesothelioma.
Related studies
- Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards — S.M. Christ, P. Heesen, et al. (2023)
- A Case of Well-Differentiated Papillary Mesothelioma of the Male Peritoneum: Successful Treatment by Systemic Chemotherapy — A. Bazine, M. Fetohi, et al. (2017)
- Successful treatment of late onset empyema after extrapleural pneumonectomy: A case report — S. Nishikawa, S. Tamari, et al. (2019)
- Successful treatment of simultaneous malignant pleural mesothelioma and pulmonary adenocarcinoma: A case report — Y. Amakusa, T. Suzuki, et al. (2024)
- Early Detection of Autism (ASD) by a Non-invasive Quick Measurement of Markedly Reduced Acetylcholine & DHEA and Increased β-Amyloid (1-42), Asbestos (Chrysotile), Titanium Dioxide, Al, Hg & often Coexisting Virus Infections (CMV, HPV 16 and 18), Bacterial Infections etc. in the Brain and Corresponding Safe Individualized Effective Treatment — Y. Omura, D. Lu, et al. (2015)
- A Rare Case of Akathisia After Removal of Subdural Hematoma During Treatment for Malignant Pleural Mesothelioma: Akathisia Induced by Brain Injury or Immune Checkpoint Inhibition — T. Wada, Y. Yano, et al. (2025)
Browse return to medical research.
How to cite it
Cite the study
S.S. Li, D.A. Steimer, S. Coy, R. Bueno. Successful treatment of a patient with oligometastatic mesothelioma to the brain. JTCVS Techniques 2020;3:358-360. doi:10.1016/j.xjtc.2020.05.019. PMID: 34317930.
Cite our summary
“Successful treatment of a patient with oligometastatic mesothelioma to the brain.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/successful-treatment-of-a-patient-with-oligometastatic-mesothelioma.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.